  Based on the information provided, here are my answers to your questions:
1. Is the treatment consistent with the diagnosis?
Yes, the treatment plan of IM EMAL 150mg daily x 3/7 and then Tabs ACT IV BD x 3/7 is consistent with the diagnosis of unspecified malaria. Both EMAL and ACT are effective antimalarial drugs that are commonly used to treat malaria.
2. Is the diagnosis consistent with the observations?
Yes, the diagnosis of unspecified malaria is consistent with the patient's history of fever, headache, and runny nose. Malaria is a common cause of fever and headache in rural areas where the patient is from.
3. Are there other things you would test, but only tests that might be available in rural health clinics?
Yes, in rural health clinics, other tests that might be available to diagnose malaria include:
* Rapid diagnostic tests (RDTs) for malaria: These are quick and easy-to-use tests that can detect malaria parasites in a patient's blood sample.
* Blood smear examination: This is a microscopic examination of a patient's blood sample to look for malaria parasites.
* Malaria ELISA test: This is a blood test that can detect malaria antigens in a patient's blood sample.
4. Is there anything else notable?
Yes, it is notable that the patient has an IUCD (Intrauterine Contraceptive Device) in situ for 2 years, which may increase the risk of malaria infection. IUCDs can create a favorable environment for malaria parasites to grow and multiply, making the patient more susceptible to malaria infection.
Overall, the treatment plan seems appropriate for the diagnosis of unspecified malaria, and the patient's observations are consistent with the diagnosis. However, it is important to keep in mind that malaria is a complex disease, and other conditions, such as typhoid fever or bacterial infections, should also be considered in the differential diagnosis.